Archive

ESMO 2014 Report: Precision medicine: Panacea or false dawn?

Written by Lorraine Carolan | 6 Nov 2014

Reports from the European Society for Medical Oncology 2014 Congress in Madrid by Denys Wheatley: In his talk on Visualising the true spectrum of cancer- will we get… read more.

Bendamustne Lymphoma Case Study

Written by Lorraine Carolan | 4 Nov 2014

Ger Walpole, CNS (Clinical Nurse Specialist), H.Dip Oncology Nursing, BNS(Hons), Sligo Regional Hospital, Sligo. Dr Andrew Hodgson, MB, BS, BSc (Hons), FRCPI, FFPath, FRCPath. Written by Karen Mas-Mollinedo… read more.

ESMO 2014 Report: Patients with Hodgkin’s lymphoma have a significantly better outcome if treated within a clinical trial

Written by Lorraine Carolan | 14 Oct 2014

by Denys Wheatley: ESMO Madrid September 2014: Session on Sunday 28 September (poster). Dr Moccia and his group in Bellinzona (Switzerland) report on the marked improvement over 30… read more.

Metformin treatment associated with low thyroid hormone

Written by Bruce Sylvester | 1 Oct 2014

by Bruce Sylvester – Researchers report that metformin therapy, a treatment for type 2 diabetes, could induce a lowering thyroid-stimulating hormone (TSH) in patients with underactive thyroids (hypothyroidism)…. read more.

ASCO Report 2014: The evolution of our molecular understanding of Colorectal Cancer

Written by Lorraine Carolan | 4 Sep 2014

What we are doing now, what the future Holds, and how Tumour profiling is just the beginning by Dr Paul Ross, Guy’s & St Thomas’ Hospitals, London. At… read more.

Press Release: Is Europe putting cancer research at risk?

Written by Lorraine Carolan | 25 Jul 2014

Lugano, Switzerland, 25 July 2014. The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General… read more.

FDA Highlights: Goserelin helps prevent early menopause caused by breast cancer treatment

Written by Bruce Sylvester | 17 Jul 2014

by Bruce Sylvester – Adding goserelin to standard chemotherapy significantly reduces the risk of early menopause in breast cancer patients, researchers reported in May of 2014 at the… read more.

Press Release: Confident but not controlled: 92% of Irish people with asthma are confident about managing their condition however 48% are deemed ‘uncontrolled’1

Written by Lorraine Carolan | 30 Jun 2014

Pan-European Survey reveals low levels of asthma control in Ireland. Irish respondents are experiencing asthma symptoms nearly 3 days a week. 48% of Irish people with asthma are… read more.

Pooled analysis of two Phase III Trials shows Halaven® (Eribulin) improves survival in advanced breast cancer

Written by Lorraine Carolan | 26 Jun 2014

Significant survival benefit observed in women with HER2 negative breast cancer – ASCO Press Release.

Lenvatinib Phase III results show significant improvement in progression-free survival in people with Radioiodine-Refractory differentiated Thyroid Cancer

Written by Lorraine Carolan | 26 Jun 2014

Pivotal phase III data for lenvatinib to be presented in a Head and Neck Cancer oral session at American Society of Clinical Oncology congress (ASCO) – Press Release.

Focused ultrasound reduces cancer pain

Written by Lorraine Carolan | 12 Jun 2014

Non-invasive focused ultrasound thermal therapy reduces pain from bone metastases. When cancer progresses and spreads to the bone, patients often suffer debilitating pain. Now, a new phase III… read more.

Treatment outcome according to tumour RAS mutation status in CRYSTAL study patients with metastatic colorectal cancer (mCRC) randomized to FOLFIRI with/without cetuximab.

Written by Lorraine Carolan | 5 Jun 2014

Adapted from Abstract 3506, which was submitted to ASCO Congress 2014 Treatment outcome according to tumour RAS mutation status in CRYSTAL study patients with metastatic colorectal cancer (mCRC) randomized… read more.

« Previous 1 … 43 44 45 46 47 … 53 Next »

Archive

Subscribe for our mailing list

Follow Us